Our company started in November 2018 with a vision to promote harm-reduction practices in Sweden. We work on promoting the usage of rapid tests for the detection of Sexually Transmitted Infections (STIs) at Point of Care (PoC) testing as well as drugscreens and testing reagents for home use as well as governmental agencies.
In 2020 as the novel coronavirus SARS-Cov-2 that leads to COVID-19 was declared a public health emergency by the World Health Organisation (WHO), we started importing one of the first developed rapid tests for detecting antibodies.
We have worked closely with the same suppliers from the beginning until now.
Our tests went through 4 validation studies so far. All studies were independent and all showed good results whether they took place in China, Iran, Norway or the United States which shows how trustworthy our tests are. The manifacturer we are partnering with have been in the market of developing medical tests for 26 years with production capabilities of up to 70,000 tests per day.
Our mission is to help whenever possible by delivering quality products that are easy to use, affordable and has the ability to save lives.